SCHEMBL4036212

SCHEMBL4036212

c1cncc(-c2cc(C3CCCN3)on2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.54
CHRNA4 P43681 4/20 0.54
CHRNA7 P36544 3/20 0.54
CYP2C19 P33261 3/20 0.49
MEN1 O00255 2/20 0.49
CYP2D6 P10635 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP2A6 P11509 2/20 0.49
CYP2C9 P11712 2/20 0.49
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2E1 P05181 1/20 0.46
CYP2B6 P20813 1/20 0.46
CHRM5 P08912 3/20 0.41
CHRM3 P20309 3/20 0.41
CHRM1 P11229 2/20 0.41
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
PPARA Q07869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16464687 0.85 NPC1 (0.51) CHRNB2CHRNA4MEN1KMT2ACHRM5
SCHEMBL16464688 0.85 NPC1 (0.51) CHRNB2CHRNA4MEN1KMT2ACHRM5
SCHEMBL11835580 0.81 RAB9A (0.55) CHRNB2CHRNA4CYP2C19MEN1KMT2A
SCHEMBL29897243 0.81 RAB9A (0.55) CHRNB2CHRNA4CYP2C19MEN1KMT2A
SCHEMBL3852291 0.79 CHRNB2 (0.42) CHRNB2CHRNA4CHRNA7CYP2C19MEN1
SCHEMBL3852286 0.79 CHRNB2 (0.42) CHRNB2CHRNA4CHRNA7CYP2C19MEN1
Hydrochloric Acid SCHEMBL5568885 0.79 CHRM5 (0.40) CHRNB2CHRNA4MEN1KMT2ACHRM5
Hydrochloric Acid SCHEMBL5567256 0.79 NOTUM (0.45) CHRNB2CHRNA4MEN1KMT2ACHRM5
SCHEMBL3852786 0.77 CHRNB2 (0.51) CHRNB2CHRNA4CHRNA7CHRM5CHRM3
SCHEMBL3852788 0.77 CHRNB2 (0.51) CHRNB2CHRNA4CHRNA7CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678169-B1 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-07-22 EP disclosed